Hi,

I was wondering if anyone would share what their current process is for transfusion associated disease/transfusion transmitted disease (TAD/TTD) specifically for:

1. Non-routinely tested at donation diseases (i.e. Lyme Disease). So, if your BB receives a report of suspected Lyme Disease from transfusion....what do you do in terms of donor questioning/testing and investigation?

2. Does anyone use surveillance of donors involved in TAD/TTD? If so, could you share an algorithm or work flow of how a donor gets on and off surveillance? Or, if you could point me towards where in regulations/standards surveillance is discussed. I may be missing it!

Many thanks!

I'm sure someone on BBT could help you with these issues, but since this post is over a year old you may already have the information.